Stay updated on Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a new Locations section listing Florida, Maryland, Michigan, and Minnesota. Updated the page revision from v3.3.2 to v3.3.3 and removed the old location blocks.
    Difference
    0.5%
    Check dated 2025-12-24T13:59:17.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Added an auto-generated PubMed note and updated the page revision to v3.3.2. Removed the older PubMed note referencing v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T14:42:32.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Removal of the funding/operational status banner that previously informed users about data timeliness and potential delays. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:26:23.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    No significant changes detected in the page content; updates appear to be minor formatting or wording adjustments without altering core study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:05:20.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    3%
    Check dated 2025-10-06T08:12:19.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Terminology and version update: 'Malignant mesothelioma' is updated to 'Mesothelioma, malignant' with a new revision tag v3.1.0 from the previous v3.0.2.
    Difference
    0.2%
    Check dated 2025-09-29T04:44:18.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab and Ramucirumab for Mesothelioma Clinical Trial page.